Clinical Trial

RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the effectiveness of Redcord treatment for neurogenic bowel dysfunction in patients with multiple sclerosis. The main objectives are: * Assess the impact of Redcord on bowel function and quality of life in multiple sclerosis patients. * Compare the outcomes of Redcord treatment with standard care practices. Participants will undergo Redcord therapy sessions and their bowel function will be monitored and compared to a control group receiving standard care. The study will measure improvements in bowel control, frequency, and overall patient satisfaction.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-17.
Trial Details
NCT Number NCT06838624
Lead Sponsor University of Castilla-La Mancha
Conditions Multiple Sclerosis, Pelvic Floor Disorder
Enrollment 76 participants
Start Date 2025-09-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-02-24